Effects of Empagliflozin on Cardiovascular Outcomes Are Consistent Across Sociodemographic Subgroups: A Real-World Analysis From the EMPRISE Study
Related Posts
Ortega-Montiel J, Alkabbani W, Hahn G, Liu J, Byrne CF, Wexler DJ, Patorno E, Paik JM. Safety of Sodium/Glucose Cotransporter 2 Inhibitors in Patients With[...]
Haridas K, Wei J, Lei L, Pham D, Jackson N, Shen N. Real-World Outcomes of Telemedicine Shared Medical Appointments in Obesity Management. Obes Sci Pract.[...]
Sharma A, Johnson M, Kim H, Kumthekar P, Yogendran L, Siegel C, Lwin Z, Koekkoek JAF, Leng L, Balogun J, Philip J. Neuropalliative Care in[...]